NO20050529L - Ciclesonidinneholdende steril vandig suspensjon - Google Patents

Ciclesonidinneholdende steril vandig suspensjon

Info

Publication number
NO20050529L
NO20050529L NO20050529A NO20050529A NO20050529L NO 20050529 L NO20050529 L NO 20050529L NO 20050529 A NO20050529 A NO 20050529A NO 20050529 A NO20050529 A NO 20050529A NO 20050529 L NO20050529 L NO 20050529L
Authority
NO
Norway
Prior art keywords
ciclesonide
aqueous suspension
sterile aqueous
containing sterile
autoclaving
Prior art date
Application number
NO20050529A
Other languages
English (en)
Other versions
NO335022B1 (no
Inventor
Kazuya Takanashi
Yoshihisa Nishibe
Atsuhiro Nagano
Yasuhide Uejima
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of NO20050529L publication Critical patent/NO20050529L/no
Publication of NO335022B1 publication Critical patent/NO335022B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en ciclesonidinneholdende vandig suspensjon sterilisert ved autoklavering, hvori ciclesonidkonsenfrasjonen etter autoklavering er 95 % eller mer sammenlignet med konsenfrasjonen før autoklavering. Foreliggende oppfinnelse tilveiebringer også en fremgangsmåte for fremstilling av en ciclesonidinneholdende steril vandig suspensjon omfattende frinnet å sterilisere en ciclesonidinneholdende vandig suspensjon ved autoklavering.
NO20050529A 2002-07-02 2005-02-01 Fremgangsmåte for fremstilling av en ciclesonidinneholdende steril vandig suspensjon NO335022B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002193399 2002-07-02
PCT/JP2003/008410 WO2004004739A1 (en) 2002-07-02 2003-07-02 Ciclesonide-containing sterile aqueous suspension

Publications (2)

Publication Number Publication Date
NO20050529L true NO20050529L (no) 2005-02-01
NO335022B1 NO335022B1 (no) 2014-08-25

Family

ID=30112281

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050529A NO335022B1 (no) 2002-07-02 2005-02-01 Fremgangsmåte for fremstilling av en ciclesonidinneholdende steril vandig suspensjon

Country Status (18)

Country Link
US (2) US8182824B2 (no)
EP (2) EP1519734A4 (no)
JP (1) JP4559221B2 (no)
KR (1) KR101020687B1 (no)
CN (1) CN100366256C (no)
AU (1) AU2003245043B2 (no)
BR (1) BRPI0312377A8 (no)
CA (1) CA2491724C (no)
EA (1) EA009843B1 (no)
HK (1) HK1080365B (no)
HR (1) HRP20050062B1 (no)
IL (1) IL165666A (no)
MX (1) MXPA04012756A (no)
NO (1) NO335022B1 (no)
NZ (1) NZ537945A (no)
PL (1) PL224989B1 (no)
RS (1) RS57455B1 (no)
WO (1) WO2004004739A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4364486B2 (ja) * 2002-07-02 2009-11-18 帝人株式会社 無菌水性懸濁製剤
JP4755495B2 (ja) * 2002-12-12 2011-08-24 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 組合せ医薬品
PT1670482E (pt) * 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
AU2005235384B2 (en) * 2004-04-20 2010-09-09 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
GB0410995D0 (en) 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
JP5661985B2 (ja) * 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
WO2011135585A2 (en) * 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
WO2022231532A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3288679A (en) * 1966-03-23 1966-11-29 Squibb & Sons Inc Steroidal compositions and method of use
US3692430A (en) * 1971-06-18 1972-09-19 John W Timmons Liquid pumping system
US3962430A (en) 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
SE8600632D0 (sv) * 1986-02-13 1986-02-13 Kabivitrum Ab Novel pharmaceutical composition
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
US6066292A (en) * 1997-12-19 2000-05-23 Bayer Corporation Sterilization process for pharmaceutical suspensions
JP2001048807A (ja) 1999-08-04 2001-02-20 Wakamoto Pharmaceut Co Ltd 難溶性薬物を水に溶解してなる製剤
WO2001028517A1 (fr) * 1999-10-20 2001-04-26 Teijin Limited Compositions therapeutiques aqueuses
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
DE60121023T2 (de) * 2000-11-24 2006-12-28 Breath Ltd., Biggin Hill Sterilisation von glucocorticosteriodsuspensionen
JP4364486B2 (ja) 2002-07-02 2009-11-18 帝人株式会社 無菌水性懸濁製剤
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
AU2004241746A1 (en) * 2003-05-22 2004-12-02 Nycomed Gmbh Salmeterol and ciclesonide combination

Also Published As

Publication number Publication date
EP1519734A1 (en) 2005-04-06
KR101020687B1 (ko) 2011-03-11
KR20050016706A (ko) 2005-02-21
HK1080365A1 (en) 2006-04-28
RS57455B1 (sr) 2018-09-28
RS113404A (sr) 2007-02-05
US20060166953A1 (en) 2006-07-27
CA2491724C (en) 2013-04-02
BR0312377A (pt) 2005-04-12
EP1519734A4 (en) 2011-02-23
CN100366256C (zh) 2008-02-06
EP3513813A1 (en) 2019-07-24
NZ537945A (en) 2007-08-31
PL224989B1 (pl) 2017-02-28
IL165666A0 (en) 2006-01-15
HRP20050062A2 (hr) 2006-04-30
HK1080365B (zh) 2008-11-28
EA200500123A1 (ru) 2005-08-25
HRP20050062B1 (hr) 2013-11-08
WO2004004739A1 (en) 2004-01-15
AU2003245043B2 (en) 2009-01-29
NO335022B1 (no) 2014-08-25
US8182824B2 (en) 2012-05-22
EA009843B1 (ru) 2008-04-28
CA2491724A1 (en) 2004-01-15
IL165666A (en) 2010-04-29
US20100034696A1 (en) 2010-02-11
JP2005535656A (ja) 2005-11-24
US8268240B2 (en) 2012-09-18
BRPI0312377A8 (pt) 2015-12-15
JP4559221B2 (ja) 2010-10-06
AU2003245043A1 (en) 2004-01-23
MXPA04012756A (es) 2005-03-23
CN1665517A (zh) 2005-09-07
PL372940A1 (en) 2005-08-08

Similar Documents

Publication Publication Date Title
NO20050529L (no) Ciclesonidinneholdende steril vandig suspensjon
AP935A (en) Quick acting chemical sterilant.
NO20063047L (no) Vandige ciclesonidsuspensjoner for forstoving
CA2357843A1 (en) Process for concentrating a sterilant and sterilizing articles therewith
GB2438152A (en) Method and apparatus for sterillizing containers
BR0308285A (pt) Ruptura de biofilmes bacterianos por meio de enzimas
JP2015104719A (ja) 弱酸性次亜塩素酸水溶液の製造方法
BR0011055A (pt) Método de esterilização
HUP0204520A2 (en) Pharmaceutical composition containing esmolol and process for its preparation
CA2602961A1 (en) Mechanized disinfection of articles
NO20044548L (no) Fremgangsmate for fremstilling av 6-alkaliden-penemderivater
EP3881942A1 (en) Plasma coating treatment method for inhibiting biological pathogen transfer
DE50203528D1 (de) Verfahren und kit zum maschinellen reinigen und desinfizieren von medizinischen instrumenten
CN107517967A (zh) 用于血液透析机的消毒液
JPWO2009098873A1 (ja) 殺菌水及びその生成方法並びにその生成装置
DE60237821D1 (de) Antibakterielle behandlung von osteoarthritis
JP2021186812A (ja) 消毒剤、消毒方法および消毒剤キット
CN101035430B (zh) 生产可植入或可移植生物材料的灭菌方法
CN202161597U (zh) 防疫用杀菌消毒箱
Saunders et al. The effect of bioburden on in-depth disinfection of denture base acrylic resin
BR0202319A (pt) Composição desinfetante e método para desinfetar e/ou esterilizar uma unidade dental
SU997686A1 (ru) Способ камерной дезинфекции твердых предметов
Muralidaran et al. Evaluation of efficacy of 2% glutaraldehyde for disinfection of hand pieces used in dentistry
CN1180848C (zh) 外科手术器械微波快速灭菌法
RU2277935C2 (ru) Способ стерилизации и набор средств для его осуществления

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ASTRAZENECA AB, SE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: COVIS PHARMA B.V., CH

CREP Change of representative

Representative=s name: BRYN AARFLOT AS, STORTINGSGATA 8, 0161 OSLO, NORGE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: COVIS PHARMA GMBH, CH

MK1K Patent expired